World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
136
Citations
60831
World Ranking
1996
National Ranking
1135

Overview

Peter A. Campochiaro is affiliated with Johns Hopkins University School of Medicine in the United States and has contributed extensively to medical research, particularly within the fields of medicine and biochemistry, genetics, and molecular biology. Their main research focus lies in ophthalmology, with a significant number of publications addressing retinal diseases, disorders, and treatments.

Their work spans multiple subfields, including ophthalmology, molecular biology, radiology, nuclear medicine, imaging, genetics, and public health. In the context of ophthalmology, their research often involves retinal diseases and treatments, retinal development and disorders, retinal imaging and analysis, glaucoma and retinal disorders, retinal and optic conditions, cell adhesion molecules research, and studies related to retinopathy of prematurity.

Peter A. Campochiaro has frequently published in notable venues such as:

  • Ophthalmology
  • The Lancet
  • Free Radical Biology and Medicine
  • JAMA Ophthalmology
  • Science Advances

They have collaborated with several researchers on multiple occasions, including primary coauthors:

  • Raquel Lima e Silva
  • Jikui Shen
  • Yogita Kanan
  • Mahmood Khan
  • Arshad M. Khanani

Among their recent publications are the following papers:

  • Sustained suppression of VEGF for treatment of retinal/choroidal vascular diseases, 2020, Progress in Retinal and Eye Research
  • Retinal vascular occlusions, 2020, The Lancet
  • The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress, 2020, Current Neuropharmacology
  • Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration, 2021, Ophthalmology
  • Gelling hypotonic polymer solution for extended topical drug delivery to the eye, 2020, Nature Biomedical Engineering

Best Publications

  • A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants

    Lars G. Fritsche;Wilmar Igl;Jessica N.Cooke Bailey;Felix Grassmann

  • Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1.

    Nicholas W. Gale;Gavin Thurston;Sean F. Hackett;Roumiana Renard

  • Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study.

    David M. Brown;Peter A. Campochiaro;Rishi P. Singh;Zhengrong Li

  • Ranibizumab for Macular Edema following Branch Retinal Vein Occlusion

    Peter A. Campochiaro;Jeffrey S. Heier;Leonard Feiner;Sarah Gray

  • Seven new loci associated with age-related macular degeneration

    Lars G. Fritsche;Lars G. Fritsche;Wei Chen;Wei Chen;Matthew Schu;Brian L. Yaspan

  • Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1

    Brian D. Kelly;Sean F. Hackett;Kiichi Hirota;Yuji Oshima

  • Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study

    Quan Dong Nguyen;Syed Mahmood Shah;Syed Mahmood Shah;Afsheen A. Khwaja;Roomasa Channa

  • Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study.

    David M. Brown;Peter A. Campochiaro;Robert B. Bhisitkul;Allen C. Ho

  • Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema

    Peter A. Campochiaro;David M. Brown;Andrew Pearson;Sanford Chen

  • VEGF is major stimulator in model of choroidal neovascularization.

    Nohoon Kwak;Naoyuki Okamoto;Jeanette M. Wood;Peter A. Campochiaro

  • Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration

    Wei Chen;Dwight Stambolian;Albert O. Edwards;Kari E. Branham

  • Ranibizumab for Macular Edema Due to Retinal Vein Occlusions: Long-term Follow-up in the HORIZON Trial

    Jeffrey S. Heier;Peter A. Campochiaro;Linda Yau;Zhengrong Li

  • Antioxidants reduce cone cell death in a model of retinitis pigmentosa.

    Keiichi Komeima;Brian S. Rogers;Lili Lu;Peter A. Campochiaro

  • Retinal and choroidal neovascularization.

    Peter A. Campochiaro

  • Molecular Pathogenesis of Retinal and Choroidal Vascular Diseases

    Peter A. Campochiaro

  • Blockade of Vascular Endothelial Cell Growth Factor Receptor Signaling Is Sufficient to Completely Prevent Retinal Neovascularization

    Hiroaki Ozaki;Man Seong Seo;Keiko Ozaki;Haruhiko Yamada

  • Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model

    Takao Tobe;Sagrario Ortega;Jose D. Luna;Hiroaki Ozaki

  • Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC)

    Benjamin M. Neale;Jesen Fagerness;Jesen Fagerness;Robyn Reynolds;Lucia Sobrin

  • Vascular Endothelial Growth Factor Is a Critical Stimulus for Diabetic Macular Edema

    Quan Dong Nguyen;Sinan Tatlipinar;Syed Mahmood Shah;Julia A. Haller

  • Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study

    Quan Dong Nguyen;Syed Mahmood Shah;Syed Mahmood Shah;Jeffery S. Heier;Diana V. Do

Frequent Co-Authors

Donald J. Zack
Donald J. Zack Johns Hopkins University School of Medicine
Aleksander S. Popel
Aleksander S. Popel Johns Hopkins University
Justin Hanes
Justin Hanes Johns Hopkins University
Nicholas Katsanis
Nicholas Katsanis Galatea Bio Inc
Kang Zhang
Kang Zhang Macau University of Science and Technology
Stephan Ripke
Stephan Ripke Massachusetts General Hospital
Mark J. Daly
Mark J. Daly Massachusetts General Hospital
Johanna M. Seddon
Johanna M. Seddon University of Massachusetts Chan Medical School
Kevin G. Peters
Kevin G. Peters Procter & Gamble (United States)
Joseph T. Coyle
Joseph T. Coyle Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in medicine but seeking flexibility, there are several online degrees and certification programs that can help launch or advance your healthcare career. Many professionals turn to options such as the cheapest online dnp programs for an affordable pathway to a Doctor of Nursing Practice degree, ideal for those aiming for advanced nursing roles.

For pharmacy careers, some learners now consider a 3-year online pharmd to expedite their journey to becoming a licensed pharmacist. These online pharmacy doctorate programs balance accessibility with comprehensive training.

Not all medical careers require long years of study. Non-clinical roles such as health records management are growing rapidly, and a health information technology online degree can prepare you for careers in data management, compliance, or administration within healthcare settings.

For those seeking quick entry into the field, earning a coding certificate is a popular route. Understanding medical coding certification cost can help you plan your education and budget effectively.

Best Scientists Citing Peter A. Campochiaro

Trending Scientists